Nu Skin Enterprises Inc.
NUS | NYSE
$4.68
+$0.10 (+2.18%)
At close: Sep 21, 2026, 4:00 PM ET
$4.65
-$0.03 (-0.64%)
Pre-market:
Sep 22, 2026, 7:45 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.49B | 1.73B | 1.97B | 2.23B | 2.7B | 2.58B |
Cost of Revenue | 453.76M | 550.23M | 611.85M | 630.92M | 675.22M | 658.03M |
Gross Profit | 1.03B | 1.18B | 1.36B | 1.59B | 2.02B | 1.92B |
Operating Income | 90.88M | -151.59M | 48.27M | 110.85M | 233.99M | 257.56M |
Interest Income | n/a | n/a | n/a | 10.38M | 11.16M | 13.12M |
Pretax Income | 196.2M | -175.05M | 26.58M | 88.97M | 232.46M | 256.23M |
Net Income | 160.2M | -146.59M | 8.6M | 104.78M | 147.27M | 191.36M |
Selling & General & Admin | 940.52M | 1.13B | 1.29B | 1.44B | 1.73B | 1.67B |
Research & Development | n/a | 13M | 22.6M | n/a | 27.2M | 23.3M |
Other Expenses | n/a | 189.36M | -2.81M | 48.49M | 24.67M | -23.3M |
Operating Expenses | 940.52M | 1.33B | 1.31B | 1.48B | 1.79B | 1.67B |
Interest Expense | 13.95M | 26.41M | 25.56M | 21.88M | 11M | 13.1M |
Selling & Marketing Expenses | 508.38M | 652.04M | 742.37M | 879.63M | 1.07B | 1.02B |
Cost & Expenses | 1.39B | 1.88B | 1.92B | 2.11B | 2.46B | 2.32B |
Income Tax Expense | 35.99M | -28.46M | 17.98M | -15.81M | 85.19M | 64.88M |
Shares Outstanding (Basic) | 49.29M | 49.66M | 49.71M | 50M | 50.19M | 52.3M |
Shares Outstanding (Diluted) | 50.3M | 49.66M | 49.86M | 50.53M | 51.43M | 52.77M |
EPS (Basic) | 3.25 | -2.95 | 0.17 | 2.10 | 2.93 | 3.66 |
EPS (Diluted) | 3.18 | -2.95 | 0.17 | 2.07 | 2.86 | 3.63 |
EBITDA | 262.41M | -78.83M | 202.98M | 174.97M | 368.48M | 331.56M |
EBIT | 210.15M | -148.64M | 133.76M | 102.46M | 243.46M | 257.56M |
Depreciation & Amortization | 52.26M | 69.81M | 69.22M | 72.51M | 125.02M | 73.99M |
Add to Watchlist
Select watchlists to add or remove NUS